Shepherd Financial Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.35M Buy
21,922
+551
+3% +$59.2K 0.25% 68
2025
Q1
$2.16M Sell
21,371
-1,353
-6% -$136K 0.25% 71
2024
Q4
$2.03M Buy
22,724
+250
+1% +$22.3K 0.24% 66
2024
Q3
$1.88M Buy
22,474
+296
+1% +$24.8K 0.23% 69
2024
Q2
$1.71M Sell
22,178
-860
-4% -$66.2K 0.22% 68
2024
Q1
$1.58M Sell
23,038
-39
-0.2% -$2.67K 0.21% 73
2023
Q4
$1.33M Buy
23,077
+114
+0.5% +$6.59K 0.19% 81
2023
Q3
$1.21M Sell
22,963
-3,507
-13% -$185K 0.19% 78
2023
Q2
$1.43M Sell
26,470
-793
-3% -$42.9K 0.22% 72
2023
Q1
$1.36M Hold
27,263
0.23% 71
2022
Q4
$1.26M Sell
27,263
-49
-0.2% -$2.27K 0.23% 69
2022
Q3
$1.06M Hold
27,312
0.21% 77
2022
Q2
$1.02M Buy
27,312
+697
+3% +$26K 0.2% 74
2022
Q1
$1.18M Sell
26,615
-3,171
-11% -$141K 0.21% 79
2021
Q4
$1.27M Sell
29,786
-2,393
-7% -$102K 0.22% 80
2021
Q3
$1.4M Buy
32,179
+77
+0.2% +$3.34K 0.27% 73
2021
Q2
$1.37M Buy
32,102
+235
+0.7% +$10.1K 0.26% 74
2021
Q1
$1.23M Buy
31,867
+3,850
+14% +$149K 0.27% 75
2020
Q4
$1.01M Sell
28,017
-10,229
-27% -$369K 0.23% 81
2020
Q3
$1.46M Sell
38,246
-724
-2% -$27.7K 0.34% 63
2020
Q2
$1.37M Buy
38,970
+497
+1% +$17.4K 0.37% 49
2020
Q1
$1.26M Sell
38,473
-766
-2% -$25K 0.43% 41
2019
Q4
$1.77M Buy
39,239
+355
+0.9% +$16K 0.41% 43
2019
Q3
$1.58M Sell
38,884
-370
-0.9% -$15.1K 0.4% 44
2019
Q2
$1.69M Sell
39,254
-152
-0.4% -$6.53K 0.32% 44
2019
Q1
$1.51M Buy
39,406
+11,107
+39% +$426K 0.29% 50
2018
Q4
$999K Sell
28,299
-859
-3% -$30.3K 0.22% 55
2018
Q3
$954K Hold
29,158
0.22% 63
2018
Q2
$960K Sell
29,158
-927
-3% -$30.5K 0.22% 63
2018
Q1
$822K Sell
30,085
-5,324
-15% -$145K 0.2% 58
2017
Q4
$879K Sell
35,409
-9,392
-21% -$233K 0.21% 60
2017
Q3
$1.31M Sell
44,801
-96
-0.2% -$2.81K 0.3% 49
2017
Q2
$1.24M Sell
44,897
-3,114
-6% -$85.9K 0.3% 49
2017
Q1
$1.17M Sell
48,011
-1,246
-3% -$30.5K 0.3% 53
2016
Q4
$1.08M Buy
+49,257
New +$1.08M 0.31% 54